ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 4.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,741,859 | +0.0% | 1,045,212 | +3.1% | 0.09% | +8.5% |
Q2 2023 | $3,741,059 | -8.4% | 1,013,837 | -17.9% | 0.08% | -2.4% |
Q1 2023 | $4,086,208 | +0.2% | 1,234,504 | +17.4% | 0.08% | -10.6% |
Q4 2022 | $4,079,374 | -79.3% | 1,051,385 | -87.1% | 0.09% | -80.9% |
Q3 2022 | $19,734,000 | -3.8% | 8,121,153 | -21.6% | 0.49% | -8.7% |
Q2 2022 | $20,514,000 | +7.7% | 10,360,400 | -0.5% | 0.54% | +21.9% |
Q1 2022 | $19,047,000 | +63.1% | 10,408,259 | +25.6% | 0.44% | +61.1% |
Q4 2021 | $11,680,000 | +230.1% | 8,283,860 | +164.6% | 0.28% | +180.6% |
Q3 2021 | $3,538,000 | +872.0% | 3,130,536 | +1276.2% | 0.10% | +716.7% |
Q2 2021 | $364,000 | +2.0% | 227,469 | +12.0% | 0.01% | -7.7% |
Q1 2021 | $357,000 | +27.5% | 203,084 | +41.5% | 0.01% | +30.0% |
Q4 2020 | $280,000 | +30.2% | 143,535 | +59.3% | 0.01% | -23.1% |
Q3 2020 | $215,000 | -17.0% | 90,082 | +1.8% | 0.01% | -27.8% |
Q2 2020 | $259,000 | -40.3% | 88,500 | -41.3% | 0.02% | -50.0% |
Q1 2020 | $434,000 | – | 150,743 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |